Aspirin in Reducing Events in the Elderly "ASPREE"

Active, not recruiting

Phase 4 Results N/A

Summary of Purpose

The ASPREE study will examine whether the potential benefits of low dose aspirin (particularly preventing heart disease, stroke, certain cancers and dementia) outweigh the risks (particularly bleeding) in people over age 65. ASPREE will determine whether taking a daily low-dose aspirin will extend the length of a disability-free life in healthy participants aged 65 years and above.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 20 July 2017.

1 Jan 2010 21 Dec 2009 1 Jan 2018 1 Jan 2018 1 Jul 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Intervention: Parallel Assignment

Contacts